Black Rock Inc. Kal Vista Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,945,116 shares of KALV stock, worth $26.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,945,116

Previous 2,432,234 21.09%

Holding current value

$26.4 Million

Previous $28.8 Million 20.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.35 - $12.49 $5.31 Million - $6.41 Million	512,882 Added 21.09%	2,945,116 $34.7 Million
Q1 2024 May 10, 2024	BUY	$11.07 - $16.04 $2.11 Million - $3.05 Million	190,209 Added 8.48%	2,432,234 $28.8 Million
Q4 2023 Feb 13, 2024	BUY	$7.58 - $12.25 $4.53 Million - $7.32 Million	597,278 Added 36.31%	2,242,025 $27.5 Million
Q3 2023 Nov 13, 2023	BUY	$8.95 - $11.35 $402,830 - $510,852	45,009 Added 2.81%	1,644,747 $15.8 Million
Q2 2023 Aug 11, 2023	BUY	$7.73 - $10.57 $321,598 - $439,754	41,604 Added 2.67%	1,599,738 $14.4 Million
Q1 2023 May 12, 2023	SELL	$6.3 - $8.39 $90,008 - $119,867	-14,287 Reduced 0.91%	1,558,134 $12.2 Million
Q4 2022 Feb 13, 2023	SELL	$4.2 - $14.24 $561,653 - $1.9 Million	-133,727 Reduced 7.84%	1,572,421 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $341,332 - $583,209	34,653 Added 2.07%	1,706,148 $24.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.16 - $15.1 $1.04 Million - $1.92 Million	127,468 Added 8.26%	1,671,495 $16.4 Million
Q1 2022 May 12, 2022	BUY	$11.2 - $16.97 $441,358 - $668,736	39,407 Added 2.62%	1,544,027 $22.8 Million
Q4 2021 Feb 10, 2022	BUY	$12.36 - $18.28 $1.09 Million - $1.61 Million	87,978 Added 6.21%	1,504,620 $19.9 Million
Q3 2021 Nov 09, 2021	SELL	$17.11 - $24.49 $167,335 - $239,512	-9,780 Reduced 0.69%	1,416,642 $24.7 Million
Q2 2021 Aug 11, 2021	BUY	$23.12 - $29.91 $33 Million - $42.7 Million	1,426,422 New	1,426,422 $34.2 Million

Others Institutions Holding KALV

# of Institutions

125

Shares Held

47.8M

Call Options Held

551K

Put Options Held

110K

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account